| RS2539457976 |
SLC27A4
|
Health Risk |
Pathogenic |
— |
| RS2539458046 |
SLC27A4
|
Health Risk |
Pathogenic |
— |
| RS2539458063 |
SLC27A4
|
Health Risk |
Likely pathogenic |
— |
| RS2539458072 |
SLC27A4
|
Health Risk |
Pathogenic |
Ichthyosis prematurity syndrome, Ichthyosis prematurity syndrome |
| RS2539458093 |
SLC27A4
|
Health Risk |
Likely pathogenic |
— |
| RS2539458101 |
SLC27A4
|
Health Risk |
Likely pathogenic |
— |
| RS2539458582 |
CACNA1B
|
Health Risk |
Likely pathogenic |
— |
| RS2539458600 |
CACNA1B
|
Health Risk |
Pathogenic |
— |
| RS2539461916 |
SLC27A4
|
Health Risk |
Pathogenic |
— |
| RS2539462332 |
SLC27A4
|
Health Risk |
Likely pathogenic |
— |
| RS2539463083 |
SLC27A4
|
Health Risk |
Pathogenic |
— |
| RS2539464264 |
LRSAM1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539464527 |
LRSAM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P-AR |
| RS2539464661 |
LRSAM1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539465699 |
SLC27A4
|
Health Risk |
Pathogenic |
— |
| RS2539465763 |
SLC27A4
|
Health Risk |
Pathogenic |
— |
| RS2539466370 |
TRAPPC9
|
Health Risk |
Pathogenic |
— |
| RS2539470565 |
LRSAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539470731 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539470786 |
LRSAM1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539470853 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2539473873 |
POMT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2539474347 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2539474441 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2539474836 |
POMT1
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2539476089 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539476287 |
POMT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539476380 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS2539476594 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539476696 |
TBK1
|
Health Risk |
Likely pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539477272 |
POMT1
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2K |
| RS2539477388 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539477949 |
POMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2539478095 |
POMT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539482429 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539487706 |
SMARCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, See cases |
| RS2539489004 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539489295 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539489532 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539490085 |
BMPR1A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS2539490128 |
FKTN
|
Health Risk |
Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2539491393 |
BMPR1A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS2539491669 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539492420 |
FREM1
|
Health Risk |
Likely pathogenic |
FREM1-related disorder, BNAR syndrome |
| RS2539493276 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539493292 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539493394 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539494403 |
BRSK2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2539494607 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2539494660 |
FKTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability) |
| RS2539494661 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539494737 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539495484 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2539495592 |
BMPR1A
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539495737 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539496182 |
BMPR1A
|
Health Risk |
Likely pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |
| RS2539503647 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539503808 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539505244 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539505252 |
GNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539505307 |
GNS
|
Health Risk |
Likely pathogenic |
GNS-related disorder, GNS-related disorder |
| RS2539505509 |
TRAPPC9
|
Health Risk |
Pathogenic |
— |
| RS2539507686 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2539507853 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539508443 |
POMT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539508466 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2539510522 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539510674 |
GNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539510842 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539510971 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539511024 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539511036 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539511295 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1F |
| RS2539514312 |
POMT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Walker-Warburg congenital muscular dystrophy |
| RS2539514362 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS2539514504 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2539514590 |
EXT2
|
Health Risk |
Likely pathogenic |
— |
| RS2539515955 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2539516907 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2539517042 |
EXT2
|
Health Risk |
Likely pathogenic |
Exostoses, multiple |
| RS2539517747 |
GNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539517850 |
GNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539519111 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539519779 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539519835 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539519932 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539520026 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539521823 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2539523565 |
GNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539523681 |
GNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539523784 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539523804 |
GNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539524933 |
GNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539525839 |
ZMYND11
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2539525878 |
TBK1
|
Health Risk |
Likely pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 |
| RS2539527738 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539527781 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539527952 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539528031 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2539528280 |
GPD1
|
Health Risk |
Pathogenic |
Transient infantile hypertriglyceridemia and hepatosteatosis, Transient infantile hypertriglyceridemia and hepatosteatosis |